Le Lézard
Classified in: Health
Subjects: HEALTH, Philanthropy

Diabetes Canada awards over $6 million in funding to new research projects


Toronto, Ontario, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Diabetes Canada is proud to announce the winners of its End Diabetes Awards, an annual competition that aims to dramatically improve the lives of people living with or at risk of type 1 and type 2 diabetes through innovative research. Each research project receives a $100,000 grant annually for three years for a total of $6.2 million in funds committed by Diabetes Canada for the research community.

"To achieve our vision of a world free of the effects of diabetes, Diabetes Canada knows that it needs to harness the transformative and combined power of technological, medical, and scientific research," says Laura Syron, President and CEO of Diabetes Canada. "Since 1975, this research grant competition has helped ensure that Canada is a global leader in research into new breakthroughs in diabetes screening, treatments and care to help improve the lives of the nearly 12 million people in Canada who live with diabetes or prediabetes."

Spanning biomedical, clinical, health services and population health research, each winning project has the potential to unlock new insights and breakthroughs in the field of diabetes management, care, and risk-reduction. Among the exciting projects funded in this year's competition, here are a few highlights:

The winning research projects for this year's Diabetes Canada's End Diabetes Awards were rigorously evaluated by scientists with expertise in diabetes research, with input from people with lived experience, and Diabetes Canada's National Research Council.

"The most important part of practicing medicine is when we can use evidence-based ways to inform care and intervene to improve the lives of individuals who live with health issues like diabetes?that doesn't happen without research. Diabetes Canada funding makes research and therefore healthcare possible, directly benefiting people living with diabetes," says Dr. Brandy Wicklow, Co-Chair of Diabetes Canada's National Research Council.

For almost 50 years, Diabetes Canada has proudly supported outstanding diabetes research in Canada, administering more than $160 million in research grants, awards and partnerships to scientists and clinicians who have dedicated their careers to the fight against diabetes.

"We are grateful for the support of our incredible community of donors, without which this research funding would not be possible. On behalf of Diabetes Canada and the nearly 1 in 3 people who live with diabetes or prediabetes in this country, your meaningful investment in the health of those who live with diabetes is making an impact," says Syron, who lives with type 2 diabetes herself.

Currently, Diabetes Canada's financial commitment to research supports over 260 researchers at 20 different research institutions across the country.

Watch our video announcement featuring Laura Syron, President and CEO of Diabetes Canada. 

Learn more about this year's winning research projects.

About Diabetes Canada

A world free of the effects of diabetes is our vision. That's why we're working together to improve the quality of life of people living with diabetes. We're sharing knowledge and creating connections for individuals and the health-care professionals who care for them; advocating through public policy; and funding research to improve treatments and find a cure to end diabetes.??

Attachment



These press releases may also interest you

at 11:20
Achieve Life Sciences, Inc. , a...

at 11:15
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, today announced the presentation of four abstracts at the American Society of Gene +...

at 11:06
PKWARE, a global leader in automated data security, have won the following awards from Cyber Defense Magazine (CDM), the industry's leading electronic information security magazine:...

at 11:05
Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The round was led by The University of Virginia Licensing and Ventures Group Seed Fund, with participation from...

at 11:05
A true changemaker for the pharmacy profession and an industry leader in vaccine...

at 11:04
ThinkCyte today announced that it will be presenting at three major international scientific conferences in the first week of May and the launch of its updated website. The company will have a presence at the American Society for Immunology (AAI)...



News published on and distributed by: